Parkside Financial Bank & Trust’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48K Sell
160
-34
-18% -$957 ﹤0.01% 1929
2026
Q1
$5.54K Hold
194
﹤0.01% 1788
2025
Q4
$7.67K Sell
194
-47
-20% -$1.72K ﹤0.01% 1671
2025
Q3
$8.5K Buy
241
+175
+265% +$6.03K ﹤0.01% 1569
2025
Q2
$2.17K Buy
66
+51
+340% +$1.66K ﹤0.01% 1976
2025
Q1
$484 Buy
+15
New +$557 ﹤0.01% 2420

Other funds holding ATRC

Parkside Financial Bank & Trust's ATRC Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its AtriCure (ATRC) stake by 18% in Q2 2026, selling an estimated $957 and leaving 160 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

Parkside Financial Bank & Trust first reported a position in ATRC in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.5K in Q3 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Parkside Financial Bank & Trust held 160 shares of AtriCure worth $4.48K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 34 AtriCure shares in Q2 2026, an estimated $957.
  • AtriCure made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1929 holding.
  • Parkside Financial Bank & Trust first reported a position in AtriCure in Q1 2025 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's AtriCure position peaked at $8.5K in Q3 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.